112239 ⎘
Vectors comprising a targeting moiety; Vectors comprising as targeting moiety peptide derived from defined protein from viruses
Sub-classes:Expressed Barcode Libraries and Uses Thereof
#2Microbial production of pure single stranded nucleic acids
#3Nucleic acid molecule encoding hepatitis B virus core protein and surface antigen protein and vaccine comprising the same
#4Compositions and methods to treat latent viral infections
#5Compositions and methods of delivering treatments for latent viral infections
#6Mutant herpes simplex virus-2 for cancer therapy
#7Chimeric glycoproteins and pseudotyped lentiviral vectors
#8Nucleic acid molecule encoding hepatitis B virus core protein and surface antigen protein and vaccine comprising the same
#9Chimpanzee adenovirus vaccine carriers
#10Viral Vectors with Improved Properties
#11Drug delivery nanocarriers targeted by landscape phage
#12Chimpanzee adenovirus vaccine carriers
#13AVV Vectors and Methods
#14CHIMERIC ADENOVIRUS, METHOD FOR PRODUCING THE SAME AND PHARMACEUTICAL USING THE SAME
#15High Transgene Expression Of A Pseudotyped Adeno-Associated Virus Type
#16Use of mutant Herpes Simplex Virus-2 for cancer therapy
#17METHODS FOR PRODUCING AND USING IN VIVO PSEUDOTYPED RETROVIRUSES
#18Modified Adenovirus Hexon Protein and Uses Thereof
#19Attenuated parainfluenza virus (PIV) vaccines
#20Recombinant viruses of the paramyxoviridae family with heterologous envelope glycoproteins
#21Drug delivery nanocarriers targeted by landscape phage
#22AAV vector for gene therapy
#23Purified trimeric S protein as vaccine against severe acute respiratory syndrome virus infections
#24Viral vectors with improved properties
#25Chimeric glycoproteins and pseudotyped lentiviral vectors
#26Peptide-enhanced transfections
#27Virus vectors and methods of making and administering the same
#28Virus vectors and methods of making and administering the same
#29Viral vectors with surface or envelope components
#30Targeting viruses using a modified sindbis glycoprotein
#31Generation of virus-like particles and use as panfilovirus vaccine
#32Retroviral delivery system
#33Pseudotyped retrovirus with modified ebola glycoprotein
#34Virus-like particles, methods of preparation, and immunogenic compositions
#35Cytokine-expressing cellular vaccines for treatment of prostate cancer
#36Targeted adenovirus vectors for delivery of heterologous genes
#37AAV vectors and methods
#38Vectors and methods for gene transfer
#39Generation of virus-like particles and use as panfilovirus vaccine
#40Recombinant mutants of rhabdovirus and methods of use thereof
#41Chimeric ebola virus envelopes and uses therefor
#42Recombinant bovine immunodeficiency virus based gene transfer system
#43Targeting gene transfer vectors to certain cell types by pseudotyping with viral glycoprotein
#44Delivery system
#45Methods for producing and using in vivo pseudotyped retroviruses
#46Continuous cell line for the production of vaccines
#47Retroviral vectors comprising a functional splice donor site and a functional splice acceptor site
#48Compositions and methods for tissue specific targeting of lentivirus vectors
#49Pseudotyped lentiviral vectors and uses thereof